227 related articles for article (PubMed ID: 26846819)
1. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.
Winship AL; Van Sinderen M; Donoghue J; Rainczuk K; Dimitriadis E
Mol Cancer Ther; 2016 Apr; 15(4):720-30. PubMed ID: 26846819
[TBL] [Abstract][Full Text] [Related]
2. Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.
Winship A; Van Sinderen M; Rainczuk K; Dimitriadis E
Oncotarget; 2017 Apr; 8(14):22716-22729. PubMed ID: 28186993
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.
Yap J; Salamonsen LA; Jobling T; Nicholls PK; Dimitriadis E
Reprod Biol Endocrinol; 2010 Jun; 8():63. PubMed ID: 20553623
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3.
Lay V; Yap J; Sonderegger S; Dimitriadis E
Int J Oncol; 2012 Aug; 41(2):759-64. PubMed ID: 22614117
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab inhibits growth, peritoneal dissemination, and lymph node and lung metastasis of endometrial cancer, and prolongs host survival.
Takahashi K; Saga Y; Mizukami H; Takei Y; Machida S; Fujiwara H; Ozawa K; Suzuki M
Int J Oncol; 2009 Oct; 35(4):725-9. PubMed ID: 19724908
[TBL] [Abstract][Full Text] [Related]
7. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 11 inhibits human trophoblast invasion indicating a likely role in the decidual restraint of trophoblast invasion during placentation.
Paiva P; Salamonsen LA; Manuelpillai U; Dimitriadis E
Biol Reprod; 2009 Feb; 80(2):302-10. PubMed ID: 18987331
[TBL] [Abstract][Full Text] [Related]
10. Fluorene-9-bisphenol inhibits epithelial-mesenchymal transition of human endometrial cancer Ishikawa cells by repressing TGF-β signaling pathway.
Wang L; Zhuang T; Li F; Wei W
Environ Sci Pollut Res Int; 2019 Sep; 26(26):27407-27413. PubMed ID: 31327139
[TBL] [Abstract][Full Text] [Related]
11. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
12. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
13. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.
Theisen ER; Gajiwala S; Bearss J; Sorna V; Sharma S; Janat-Amsbury M
BMC Cancer; 2014 Oct; 14():752. PubMed ID: 25300887
[TBL] [Abstract][Full Text] [Related]
14. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
15. Host IL11 Signaling Suppresses CD4
Huynh J; Baloyan D; Chisanga D; Shi W; O'Brien M; Afshar-Sterle S; Alorro M; Pang L; Williams DS; Parslow AC; Thilakasiri P; Eissmann MF; Boon L; Masson F; Chand AL; Ernst M
Cancer Immunol Res; 2021 Jul; 9(7):735-747. PubMed ID: 33906864
[TBL] [Abstract][Full Text] [Related]
16. miR‑23b inhibits proliferation of SMMC‑7721 cells by directly targeting IL‑11.
Jiang T; Huang Z; Zhang S; Zou W; Xiang L; Wu X; Shen Y; Liu W; Zeng Z; Zhao A; Zhou S; Zeng Q
Mol Med Rep; 2018 Aug; 18(2):1591-1599. PubMed ID: 29901200
[TBL] [Abstract][Full Text] [Related]
17. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
18. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X; Yan Q; Zhang Z; Du G; Wan X
Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
[TBL] [Abstract][Full Text] [Related]
19. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.
Pedrola N; Devis L; Llauradó M; Campoy I; Martinez-Garcia E; Garcia M; Muinelo-Romay L; Alonso-Alconada L; Abal M; Alameda F; Mancebo G; Carreras R; Castellví J; Cabrera S; Gil-Moreno A; Matias-Guiu X; Iovanna JL; Colas E; Reventós J; Ruiz A
Clin Exp Metastasis; 2015 Jun; 32(5):467-78. PubMed ID: 25924802
[TBL] [Abstract][Full Text] [Related]
20. IL-6 promotes endometrial cancer cells invasion and migration through signal transducers and activators of transcription 3 signaling pathway.
Che Q; Xiao X; Liu M; Lu Y; Dong X; Liu S
Pathol Res Pract; 2019 Jun; 215(6):152392. PubMed ID: 30922625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
